Medmix Ltd
SIX:MEDX
Medmix Ltd
SIX:MEDX
Price:
9.42
CHF
-2.79%
Market Closed
Market Cap:
CHf388.7m
Balance Sheet
Balance Sheet Decomposition
Medmix Ltd
Medmix Ltd
Balance Sheet Decomposition is not available for
Medmix Ltd
Medmix Ltd
Balance Sheet
Medmix Ltd
Medmix Ltd
Currency: CHF
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
16
|
5
|
15
|
210
|
314
|
112
|
96
|
|
| Cash |
15
|
3
|
14
|
209
|
105
|
109
|
94
|
|
| Cash Equivalents |
2
|
2
|
1
|
1
|
208
|
3
|
2
|
|
| Short-Term Investments |
68
|
75
|
31
|
0
|
3
|
0
|
0
|
|
| Total Receivables |
56
|
38
|
39
|
37
|
67
|
74
|
59
|
|
| Accounts Receivables |
44
|
30
|
26
|
29
|
61
|
58
|
46
|
|
| Other Receivables |
12
|
8
|
12
|
9
|
6
|
16
|
13
|
|
| Inventory |
64
|
62
|
63
|
79
|
92
|
88
|
75
|
|
| Other Current Assets |
12
|
7
|
7
|
13
|
14
|
33
|
31
|
|
| Total Current Assets |
215
|
187
|
155
|
340
|
489
|
308
|
261
|
|
| PP&E Net |
118
|
152
|
207
|
230
|
230
|
258
|
262
|
|
| PP&E Gross |
118
|
152
|
207
|
230
|
230
|
258
|
262
|
|
| Accumulated Depreciation |
141
|
148
|
150
|
164
|
163
|
173
|
191
|
|
| Intangible Assets |
160
|
137
|
159
|
136
|
120
|
128
|
117
|
|
| Goodwill |
222
|
217
|
263
|
258
|
254
|
269
|
272
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
7
|
13
|
8
|
|
| Other Long-Term Assets |
4
|
4
|
6
|
11
|
6
|
31
|
34
|
|
| Other Assets |
222
|
217
|
263
|
258
|
254
|
269
|
272
|
|
| Total Assets |
718
N/A
|
697
-3%
|
790
+13%
|
974
+23%
|
1 106
+13%
|
1 007
-9%
|
954
-5%
|
|
| Liabilities | ||||||||
| Accounts Payable |
42
|
38
|
30
|
41
|
47
|
49
|
39
|
|
| Accrued Liabilities |
22
|
23
|
22
|
28
|
36
|
31
|
34
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
10
|
17
|
53
|
24
|
164
|
42
|
21
|
|
| Other Current Liabilities |
19
|
28
|
30
|
24
|
23
|
56
|
68
|
|
| Total Current Liabilities |
93
|
106
|
134
|
117
|
271
|
178
|
163
|
|
| Long-Term Debt |
250
|
259
|
279
|
297
|
309
|
308
|
303
|
|
| Deferred Income Tax |
29
|
24
|
27
|
20
|
16
|
19
|
17
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
9
|
10
|
|
| Other Liabilities |
7
|
13
|
16
|
7
|
5
|
28
|
26
|
|
| Total Liabilities |
378
N/A
|
402
+6%
|
457
+14%
|
441
-4%
|
601
+36%
|
542
-10%
|
518
-4%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
339
|
304
|
346
|
553
|
540
|
530
|
499
|
|
| Treasury Stock |
0
|
0
|
0
|
7
|
13
|
15
|
15
|
|
| Other Equity |
1
|
9
|
12
|
13
|
23
|
50
|
48
|
|
| Total Equity |
340
N/A
|
295
-13%
|
333
+13%
|
534
+60%
|
505
-5%
|
465
-8%
|
436
-6%
|
|
| Total Liabilities & Equity |
718
N/A
|
697
-3%
|
790
+13%
|
974
+23%
|
1 106
+13%
|
1 007
-9%
|
954
-5%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
34
|
34
|
34
|
41
|
41
|
41
|
41
|
|
Switch to:
Switch to:
See Also
Discover More
